Tykerb 250 mg Tablet
Request Pricing & Availability
Fill in your details below and our clinical team will get back to you with pricing & availability within 24 hours.
Similar Products
| Product | Manufacturer / Marketed By | Price |
|---|---|---|
Hertab 250 mg Tablet
|
Hetero Healthcare | Ask for Price |
|
Combinib 250 mg Tablet
|
Cipla | Ask for Price |
Herduo 250 mg Tablet
|
Natco Pharma | Ask for Price |
Description
Tykerb 250 mg Tablets are manufactured by NOVARTIS INDIA LTD in United Kingdom and contain 250 mg of Lapatinib per tablet. Each Bottle includes 30 tablets per bottle, making Tykerb 250 mg Tablets an effective option for Breast Cancer . Prescription Required from your healthcare provider to purchase Lapatinib medicine. Indogenmed deals in all type of generic Lapatinib medicine.
Related Products
-
Zyceva 100 mg Tablet
ErlotinibPrice on request
Request pricing -
Imatikast 400 mg Tablet
ImatinibPrice on request
Request pricing -
Pomalid 1 Mg Capsule
PomalidomidePrice on request
Request pricing -
Pomalid 2 Mg Capsule
PomalidomidePrice on request
Request pricing -
Pazonat 200 mg Tablet
PazopanibPrice on request
Request pricing -
CA Atra 10 mg Softgel Capsule
TretinoinPrice on request
Request pricing -
Sutinat 25 mg Capsule
SunitinibPrice on request
Request pricing -
Sutinat 12.5 mg Capsule
SunitinibPrice on request
Request pricing -
Spnib 100 mg Tablet
DasatinibPrice on request
Request pricing -
Azatend 100 mg Injection
AzacitidinePrice on request
Request pricing -
Tegonat 15 mg Capsule
TegafurPrice on request
Request pricing -
Bdenza 40 mg Capsule
EnzalutamidePrice on request
Request pricing
Related Reading
-
FDA Approves Vepdegestrant for ER+/HER2–, ESR1-Mutated Breast Cancer: A New Targeted Option
Medical Review: This article was reviewed by Dr. Sophie Reynolds on May 6, 2026. Breast cancer treatment continues to evolve
-
First-Line Palbociclib Combination Boosts PFS in HR+/HER2+ mBC – PATINA Findings
Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 1, 2026. n Metastatic breast cancer (mBC) remains
-
Atirmociclib and Fulvestrant Together Delay Cancer Progression in HR+/HER2– Cases
Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 23, 2026. Advancements in breast cancer treatment continue
-
Healing After Radiation: Is a Nipple-Sparing Mastectomy Possible?
Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 20, 2026. n For many years, patients who
-
Oral SERDs Explained: The New Hormone Therapy Option After Endocrine Resistance in HR+ Breast Cancer
Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 25, 2026. n Hormone receptor-positive, HER2-negative breast cancer
-
Does Ribociclib Still Help After 3 Years? The NATALEE Trial’s 4-Year Follow-Up Answers
Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 21, 2026. n For patients with hormone receptor–positive,
Shipping & Delivery
- Ships from
- India, worldwide delivery
- Order processing
- 1–3 business days after checks
- Transit time
- 5–7 business days by express courier
- Tracking
- Tracking number sent by email or SMS
- Packaging
- Discreet, tamper-evident, cold-chain available
- Duties & taxes
- Payable by the recipient on import